Topiramate 68382-0769-01
- Manufacturer
- Zydus Pharmaceuticals Usa Inc.
- Dosage Form
- Capsule, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- September 10, 2024
- Listing Expires
- December 31, 2027
- Application
- ANDA207382
Need to source Topiramate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Topiramate | 100 mg/1 |
Drug Class
Cytochrome P450 2C19 Inhibitors [MoA]Cytochrome P450 3A4 Inducers [MoA]Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
68382-0769-01Selected100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-769-01)
Other packages for this product(4)
500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-769-05)
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-769-06)
90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-769-16)
3 BLISTER PACK in 1 CARTON (68382-769-78) / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (68382-769-30)